Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Decibel Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +4 vs. Q3 2021
- Shares held
- 17.6M
- −1.36M (−7.2%) vs. Q3 2021
- Total value
- $81.7M
- −$64.2M (−44.0%) vs. Q3 2021
- New holders
- 10
- 3 more added
- Sold out
- 6
- 12 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 95 | $0 | 0.00% | +95 | New |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% | +300 | New |
| Citigroup Inc | 751 | $3.00K | 0.00% | +751 | New |
| Royal Bank of Canada | 1,075 | $5.00K | 0.00% | −1,000−48.2% | Reduced |
| Optiver Holding B.V. | 867 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,409 | $7.00K | 0.00% | +1,409 | New |
| Acadian Asset Management LLC | 4,283 | $19.0K | 0.00% | +4,283 | New |
| Flagship Harbor Advisors, LLC | 10,113 | $47.0K | 0.00% | +10,113 | New |
| Two Sigma Advisers, LP | 11,300 | $53.0K | 0.00% | +11,300 | New |
| Morgan Stanley | 13,262 | $62.0K | 0.00% | −14,892−52.9% | Reduced |
| Bank of America Corp | 13,723 | $64.0K | 0.00% | −5,550−28.8% | Reduced |
| Northern Trust Corp | 14,239 | $67.0K | 0.00% | −1,000−6.6% | Reduced |
| Federated Hermes, Inc. | 15,000 | $70.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 15,053 | $70.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,700 | $73.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 18,472 | $86.0K | 0.02% | +18,472 | New |
| Bank of New York Mellon Corp | 27,310 | $127.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 38,656 | $180.0K | 0.00% | +120+0.3% | Added |
| Susquehanna International Group, LLP | 39,426 | $183.0K | 0.00% | +17,000+75.8% | Added |
| Atlas Capital Advisors LLC | 41,025 | $190.8K | 0.03% | 00.0% | Unchanged |
| FMR LLC | 43,500 | $202.0K | 0.00% | −170,300−79.7% | Reduced |
| Two Sigma Investments, LP | 47,368 | $220.0K | 0.00% | +47,368 | New |
| Renaissance Technologies LLC | 50,900 | $237.0K | 0.00% | +50,900 | New |
| Neuberger Berman Group LLC | 59,570 | $277.0K | 0.00% | +16,035+36.8% | Added |
| Geode Capital Management, LLC | 69,283 | $322.0K | 0.00% | −273−0.4% | Reduced |
| Bridgeway Capital Management, LLC | 114,928 | $534.0K | 0.01% | 00.0% | Unchanged |
| Bronte Capital Management Pty Ltd. | 157,216 | $731.0K | 0.09% | −2,246−1.4% | Reduced |
| JPMorgan Chase & Co | 160,525 | $746.0K | 0.00% | −4,844−2.9% | Reduced |
| Suvretta Capital Management, LLC | 263,600 | $1.23M | 0.02% | 00.0% | Unchanged |
| Woodline Partners LP | 275,001 | $1.28M | 0.02% | −5,472−2.0% | Reduced |
| Harvard Management Co Inc | 328,798 | $1.53M | 0.14% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $2.30M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 624,797 | $2.91M | 0.00% | −418−0.1% | Reduced |
| Samsara BioCapital, LLC | 826,422 | $3.84M | 0.77% | 00.0% | Unchanged |
| BlackRock Inc. | 1,096,213 | $5.10M | 0.00% | −725,337−39.8% | Reduced |
| Casdin Capital, LLC | 1,170,048 | $5.44M | 0.15% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $7.61M | 0.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,773,561 | $8.25M | 0.01% | −4,098−0.2% | Reduced |
| TRV GP III, LLC | 3,139,685 | $14.6M | 3.65% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $23.0M | 0.30% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −297,711−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −251,950−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −19,968−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |